Korean J Health Promot.  2017 Sep;17(3):199-207. 10.15384/kjhp.2017.17.3.199.

Factors Affecting Health-related Quality of Life in Middle-aged Male Patients with Benign Prostatic Hyperplasia

• Kim D
• Lee SK

• KMID: 2391312
• DOI: http://doi.org/10.15384/kjhp.2017.17.3.199

Abstract

BACKGROUND
This study was conducted to provide a fundamental data and improve health-related quality of life (HRQoL) in increasing population of middle-aged male patients with benign prostatic hyperplasia (BPH) by investigating and analyzing the factors affecting the HRQoL.
METHODS
The survey was performed with 124 middle-aged male BPH patients of Fatima hospital located in Daegu city. The data were collected by questionnaires and were analyzed by using SPSS WIN ver. 18.0 (IBM Corp., New York, NY, USA).
RESULTS
Severity of BPH in participants was classified into moderate (54%), severe (31.5%), and mild (14.5%). The mean HRQoL score was 3.78 points. The scores in each section were 4.18 points for "˜disability of daily living activity', 3.95 points for "˜discomfort due to BPH', 3.69 points for "˜psychological state', 3.65 points for "˜anxiety' and 2.93 points for "˜sex life'. Perceived health state presented positive correlation with HRQoL and negative correlation with BPH symptoms. The BPH symptoms showed negative correlation with HRQoL. The level of BPH symptoms, perceived health status and prostate volume were revealed to influence the HRQoL in the order of the degree of influence. The factors' determination value was 63.0%.
CONCLUSIONS
It was confirmed that the lower the patient's level of BPH symptoms is, the better the perceived health status is and that the smaller the prostate volume is, the higher the HRQoL is. Therefore, administration of medicine that relieves BPH symptoms and reduces a volume of the prostate should be encouraged and sustainable education, customized treatment and nursing care should be provided.

Keyword

Middle aged; Prostatic hyperplasia; Quality of life

MeSH Terms

Daegu
Education
Humans
Male*
Middle Aged
Nursing Care
Prostate
Prostatic Hyperplasia*
Quality of Life*

Reference

1.Fourcade RO., Lacoin F., Rouprêt M., Slama A., Le Fur C., Michel E, et al. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol. 2012. 30(3):419–26.

2.Quek KF. Factors affecting health–related quality of life among patients with lower urinary tract symptoms. Int J Urol. 2005. 12(12):1032–6.

3.National Health Insurance Service. Allowance status by disease classification by age [Internet]. Daejeon: Statistics Korea;2016. [Accessed Oct 30, 2016]. Available from:. http://ko-sis.kr/statHtml/statHtml.do?orgId=350&tblId=TX_35001_A061&vw_cd=MT_TM2_TITLE&list_id=101_B3102&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=MT_TM2_TITLE&path=%252FcustomStatis%252FcustomStatis_02List.jsp#.

4.Lee E., Yoo KY., Kim Y., Shin Y., Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol. 1998. 33(1):17–21.

5.National Health Insurance Service. Pain in men only. Benign Prostatic hyperplasia [Internet]. Sejong: Ministry of Health and Welfare;2014. [Accessed Mar 14, 2016]. Availaber from:. http://www.mohw.go.kr/front_new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&BOARD_ID=140&BOARD_FLAG=00&CONT_SEQ=299250&page=1.

6.Kim DH., Kwon HY. Clinical characteristics of frequency-anxiety syndrome. Korean J Urol. 2001. 42(8):858–63.

7.Lee NR., Kim KH., Kwak YH., Kim YJ. Effects of the symptoms, anxiety, and depression on the quality of sleep of benign prostate hyperplasia patients. J Korea Cont Assoc. 2015. 15(1):338–49.

8.Kim JS., Moon VN. Factors influencing health-related quality of life in patients with benign prostatic hyperplasia. J Korean Acad Nurs. 2010. 40(2):287–97.

9.Hunter DJ., McKee M., Black NA., Sanderson CF. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology. 1995. 45(6):962–71.

10.Salinas Sánchez AS., Hernández Millán IR., Segura Martin M., Lorenzo Romero JG., Virseda Rodríguez JA. The impact of benign prostatic hyperplasia surgery on patients' quality of life. Urol Int. 2002. 68(1):32–7.

11.Suzuki H., Yano M., Awa Y., Nakatsu H., Egoshi K., Mikami K, et al. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey. Int J Urol. 2006. 13(9):1202–6.

12.Na DM., Kim GN., Lee KO. A Study on the relationship between self-esteem and depression of benign prostatic hyper-plagia patients. Med J Chosun Univ. 1995. 20(2):158–68.

13.Kim E., Park H., Kim H., Chang N. Diet and lifestyle risk factors of benign prostatic hyperplasia. Korean J Nutr. 2007. 40(3):249–58.

14.Chang SJ. Factors affecting health-related quality of life of the benign prostate hyperplasia patients [dissertation]. Busan: Donga University;2006. Korean.

15.Yim PW., Wang W., Jiang Y., Zakir HA., Toh PC., Lopez V, et al. Health-related quality of life, psychological well-being, and sexual function in patients with benign prostatic hyperplasia after prostatic surgery. Appl Nurs Res. 2015. 28(4):274–80.

16.Kim YH. Study of the relations between health conception, benign prostatic hyperplasia symptoms and quality of life of mid-aged men. Taehan Kanho. 1997. 36(5):41–4.

17.Calvert MJ., Freemantle N. Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life? J Clin Pharm Ther. 2003. 28(6):513–21.

18.An HM. Factors of health related quality of life of Korea male and female adults according to life cycle: by using 4th National Health and Nutrition Examination Survey [dissertation]. Seoul: Yonsei University;2010. Korean.

19.Lee YW. A study of quality of life in middle-aged men. J Korean Acad Nurs. 2002. 32(4):539–49.

20.Choi HR., Chung WS., Shim BS., Kwon SW., Hong SJ., Chung BH, et al. Translation validity and reliability of I-PSS Korean version. Korean J Urol. 1996. 37(6):659–65.

21.Barry MJ., Fowler FJ Jr., O'Leary MP., Bruskewitz RC., Holtgrewe HL., Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992. 148(5):1549–57. discussion 1564.

22.Epstein RS., Deverka PA., Chute CG., Panser L., Oesterling JE., Lieber MM, et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol. 1992. 45(12):1431–45.

23.Girman CJ., Jacobsen SJ., Tsukamoto T., Richard F., Garraway WM., Sagnier PP, et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998. 51(3):428–36.

24.Rosen R., Altwein J., Boyle P., Kirby RS., Lukacs B., Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003. 44(6):637–49.

25.Kim MS. Affecting factors to the quality of life in patients with benign prostatic hyperplasia [dissertation]. Seoul: Yonsei University;2008. Korean.

26.Sánchez-Cruz JJ., Cabrera-León A., Martín-Morales A., Fernández A., Burgos R., Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003. 44(2):245–53.

27.Philippou YA., Steggall MJ., Treacy CL., Hirani S., O'Driscoll ST., Bakker CJ, et al. Penile rehabilitation for post-prostatectomy erectile dysfunction. Cochrance Database Syst Rev. 2016. 11:CD012414.

28.McVary KT., Roehrborn CG., Avins AL., Barry MJ., Brus-kewitz RC., Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011. 185(5):1793–803.

29.Kim HS. The development & evaluation of self care agency promoting program for prostatectomy patient [dissertation]. Seoul: Korea University;2007. Korean.